[Regression of the lipoidic corneal arch. Experience with CPIB (ethyl chlorophenoxyisobuyrate). Preliminary report].
D000328:Adult; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D001796:Blood Protein Disorders / Q000188:drug therapy; D003317:Corneal Dystrophies, Hereditary / Q000188:drug therapy* / Q000276:immunology; D005260:Female; D006801:Humans; D007022:Hypotension / Q000188:drug therapy*; D008074:Lipoproteins / Q000032:analysis; D008297:Male; D011422:Propionates / Q000627:therapeutic use*
D000924:Anticholesteremic Agents; D008074:Lipoproteins; D011422:Propionates
Regressão do arco lipoídico corneano. Experiências com CPIB (clorofenoxiisobutirato de etila). Nota prévia.